Trinity Bio ADR (TRIB)

$0.62 -0.01 (-1.78%)
Market Cap 11.46M
Revenue (ttm) 61.56M
Net Income (ttm) -31.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -51.64%
Debt to Equity Ratio -2.06
Volume 26,000
Avg Vol 56,104
Day's Range N/A - N/A
Shares Out 18.05M
Stochastic %K 14%
Beta 0.84
Analysts Strong Buy
Price Target $15.00

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles,...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 276 9800
Fax: 353 1 276 9888
Address:
IDA Business Park, Bray, Ireland
Think_Bigly
Think_Bigly Jun. 11 at 2:57 PM
$TRIB IMO.. one more bucket of dirt gets dumped on this..
0 · Reply
JAG_2_Trade
JAG_2_Trade Jun. 3 at 6:52 PM
$TRIB this still exists? 2 months ago..... Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
0 · Reply
ajmore
ajmore May. 30 at 12:22 PM
$TRIB cgm data will bring a squeeze as good as the $SBET one!
1 · Reply
kadeee
kadeee May. 29 at 7:36 PM
$TRIB Hello earnings! $IMVT $IMNN
1 · Reply
JAG_2_Trade
JAG_2_Trade May. 29 at 12:41 PM
$TRIB this is going to be dead.
1 · Reply
GuineaPigForever
GuineaPigForever May. 28 at 2:45 PM
$TRIB Just after I post that below. They filled my order and then bought a very small order into the lowest bid again.
0 · Reply
GuineaPigForever
GuineaPigForever May. 28 at 2:42 PM
$TRIB I find it odd. Are market makers setting the low bid? I always put in a limit order just above the lowest bid. After I do that, it never seems to drop down by my bid allowing it to fill. If I dont set up the limit order that day, they buy small amounts (very small) into the low bid dropping it all day long. I know little ole me does not make a difference but it seems to be this way all the time.
0 · Reply
mechaniker06
mechaniker06 May. 28 at 11:17 AM
$TRIB trinity has been around for over 30 years, shocked some billion dollar big pharma has not bought them for pocket change and acquired their entire portfolio
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
$TRIB $TRIL $HOOK
2 · Reply
Super5Investments
Super5Investments May. 23 at 12:34 AM
$TRIB On September 6, 2022, the Securities and Exchange Commission announced that New York-based, registered investment advisor Perceptive Advisors LLC (“Investment Advisor”) had agreed to pay a $1.5 million civil penalty for allegedly failing to disclose conflicts of interest regarding ownership of its personnel in sponsors
0 · Reply
Latest News on TRIB
Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

May 15, 2025, 4:00 PM EDT - 4 weeks ago

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Mar 14, 2025, 4:30 PM EDT - 3 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Mar 13, 2025, 7:30 AM EDT - 3 months ago

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Feb 28, 2025, 8:30 AM EST - 3 months ago

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Feb 6, 2025, 7:30 AM EST - 4 months ago

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Jan 28, 2025, 7:20 AM EST - 5 months ago

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 24, 2024, 8:33 AM EST - 6 months ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Dec 18, 2024, 11:00 AM EST - 6 months ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 12:37 PM EST - 7 months ago

Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 9:00 AM EST - 7 months ago

Trinity Biotech Announces Q3 2024 Financial Results

Trinity Biotech to Announce Q3 2024 Financial Results

Nov 14, 2024, 8:07 AM EST - 7 months ago

Trinity Biotech to Announce Q3 2024 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Nov 7, 2024, 8:19 AM EST - 7 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 8 months ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 25, 2024, 8:45 AM EDT - 8 months ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Oct 7, 2024, 8:15 AM EDT - 9 months ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 24, 2024, 4:05 PM EDT - 9 months ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 18, 2024, 4:05 PM EDT - 9 months ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Sep 9, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Sep 3, 2024, 9:55 AM EDT - 10 months ago

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Aug 26, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Aug 20, 2024, 5:00 PM EDT - 10 months ago

Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 3:43 AM EDT - 10 months ago

Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript

Trinity Biotech Announces Q2 2024 Financial Results

Aug 14, 2024, 7:30 AM EDT - 10 months ago

Trinity Biotech Announces Q2 2024 Financial Results

Trinity Biotech to Announce Q2 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 10 months ago

Trinity Biotech to Announce Q2 2024 Financial Results

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Aug 2, 2024, 9:24 AM EDT - 11 months ago

Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Trinity Biotech Announces Appointment of A New CFO

Jul 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Appointment of A New CFO

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Jun 24, 2024, 7:00 AM EDT - 1 year ago

Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM Sensor

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Jun 10, 2024, 9:10 AM EDT - 1 year ago

Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

Jun 3, 2024, 4:00 AM EDT - 1 year ago

Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

May 23, 2024, 6:44 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

May 23, 2024, 8:00 AM EDT - 1 year ago

Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance

Trinity Biotech plc to Announce Q1 2024 Financial Results

May 21, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q1 2024 Financial Results

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

May 16, 2024, 9:18 AM EDT - 1 year ago

Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

May 13, 2024, 11:42 AM EDT - 1 year ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

May 8, 2024, 10:36 AM EDT - 1 year ago

Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Apr 4, 2024, 3:03 PM EDT - 1 year ago

Trinity Biotech plc (TRIB) Q4 2023 Earnings Call Transcript

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Mar 28, 2024, 6:39 PM EDT - 1 year ago

Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial Results

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Mar 8, 2024, 10:03 AM EST - 1 year ago

Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Feb 15, 2024, 12:34 PM EST - 1 year ago

Trinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Feb 13, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Trinity Biotech to Present at Emerging Growth Conference

Feb 8, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech to Present at Emerging Growth Conference

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Feb 7, 2024, 8:30 AM EST - 1 year ago

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)

Jan 31, 2024, 5:14 PM EST - 1 year ago

Trinity Biotech plc (TRIB) Acquisition of the CGM Assets of Waveform Technologies and Q3 2023 Earnings Call (Transcript)

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Jan 31, 2024, 7:05 AM EST - 1 year ago

Trinity Biotech Announces Q3 2023 Financial Results & Business Update

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Jan 31, 2024, 7:02 AM EST - 1 year ago

Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and India

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Jan 31, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.

Trinity Biotech plc to Host Investor Call

Jan 30, 2024, 5:23 PM EST - 1 year ago

Trinity Biotech plc to Host Investor Call

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Dec 27, 2023, 8:57 AM EST - 1 year ago

Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Kenya

Think_Bigly
Think_Bigly Jun. 11 at 2:57 PM
$TRIB IMO.. one more bucket of dirt gets dumped on this..
0 · Reply
JAG_2_Trade
JAG_2_Trade Jun. 3 at 6:52 PM
$TRIB this still exists? 2 months ago..... Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
0 · Reply
ajmore
ajmore May. 30 at 12:22 PM
$TRIB cgm data will bring a squeeze as good as the $SBET one!
1 · Reply
kadeee
kadeee May. 29 at 7:36 PM
$TRIB Hello earnings! $IMVT $IMNN
1 · Reply
JAG_2_Trade
JAG_2_Trade May. 29 at 12:41 PM
$TRIB this is going to be dead.
1 · Reply
GuineaPigForever
GuineaPigForever May. 28 at 2:45 PM
$TRIB Just after I post that below. They filled my order and then bought a very small order into the lowest bid again.
0 · Reply
GuineaPigForever
GuineaPigForever May. 28 at 2:42 PM
$TRIB I find it odd. Are market makers setting the low bid? I always put in a limit order just above the lowest bid. After I do that, it never seems to drop down by my bid allowing it to fill. If I dont set up the limit order that day, they buy small amounts (very small) into the low bid dropping it all day long. I know little ole me does not make a difference but it seems to be this way all the time.
0 · Reply
mechaniker06
mechaniker06 May. 28 at 11:17 AM
$TRIB trinity has been around for over 30 years, shocked some billion dollar big pharma has not bought them for pocket change and acquired their entire portfolio
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
$TRIB $TRIL $HOOK
2 · Reply
Super5Investments
Super5Investments May. 23 at 12:34 AM
$TRIB On September 6, 2022, the Securities and Exchange Commission announced that New York-based, registered investment advisor Perceptive Advisors LLC (“Investment Advisor”) had agreed to pay a $1.5 million civil penalty for allegedly failing to disclose conflicts of interest regarding ownership of its personnel in sponsors
0 · Reply
Super5Investments
Super5Investments May. 23 at 12:31 AM
$TRIB Glad i sold this garbage awhile ago. This company only knows how to lose. Investors laugh at them.
2 · Reply
GuineaPigForever
GuineaPigForever May. 23 at 12:30 AM
$TRIB check out the last three trades of after hours. 1 share traded at .73 1 share traded at .72 and then 1 share traded at .71 Algos pinging for lower bids. This will pump soon when algos are pinging for the bottom.
0 · Reply
Think_Bigly
Think_Bigly May. 19 at 7:34 PM
$TRIB -imagine a $20M IPO in the CGM space? Never happen. An innovative CGM IPO would be 10x our $20M.. and that's the view from the hedge.
0 · Reply
JohnDizzel1
JohnDizzel1 May. 19 at 7:20 PM
$TRIB lol this company couldn’t do shiet during covid not going to do anything now
0 · Reply
Clydagh
Clydagh May. 19 at 3:13 PM
$TRIB part 2 Why do Perceptive keep funding? With a lot more cash needed i dont see them drip-feeding $5M every 2 months. Their cash is a stopgap pending new funds. I see 3 options for new cash 1) Imminent sale of a line of business. I think Perceptive are forcing this - we saw an extraordinary about turn from Trib buying business in Dec to now selling. 2) CGM deal with cash upfront 3) CGM deal with no cash up front but new share sales "at the window" riding the wave of good news. Probably an expanded "at the window" or some other rights issue to follow. They do say another CGM trial has just ended - might this be the one where Bayer finally sign up? We know 1) is on the cards anyway as Barclays engaged. If there is any good news they will probably kill it with an "at-the-window" share sale so grab what you can. In other words a line-of-business sale will probably have an a matching "at the window" sale of new shares.
1 · Reply
Clydagh
Clydagh May. 19 at 3:05 PM
$TRIB part1 Q4 grim. Decent $15M Rev but losses exceed Rev!! Mostly restructuring? Q1 rev will halve. Due to moving production and a bit US Aid related. Worse, production will not fully recover until late Q2 and into Q3 (although on higher margin). The promised great Q2 Ebita story from all last year - canned. Cash burn has been brutal. In the last half of 2024 new share sales (at the window) raised $7.6m. Then they got $5.5m on Dec 24 which is in the Q4 numbers. The closed Q4 with $5M so must have been broke on Christmas eve. Then $4M in Feb. $4.5m on 14 May. Those 3 injections were not all cash - include unpaid interest. Part of the restructure is on hold - because of tariffs they don't know whether on not to close one US centre. Only bright spot - they say HIV orders are about to pick up. Heard that before.
0 · Reply
Think_Bigly
Think_Bigly May. 16 at 7:59 PM
$TRIB Perceptive is their partner. IMMCO has to go. They are going for CGM full tilt.
0 · Reply
Brasiljunior
Brasiljunior May. 16 at 3:33 PM
$TRIB https://www.stocktitan.net/news/TRIB/trinity-biotech-publishes-fourth-quarter-and-fiscal-year-2024-gnluh334wiwt.html
0 · Reply
GuineaPigForever
GuineaPigForever May. 16 at 2:20 PM
$TRIB yep, more tiny trades into the low bids, some single share trades (algos pinging for liquidity) then larger purchases right after. Algos, what are you up to?
0 · Reply
GuineaPigForever
GuineaPigForever May. 16 at 1:11 PM
$TRIB tiny trades of just a few shares being sold into the low bids this morning. What to make of it?
0 · Reply
ajmore
ajmore May. 16 at 12:18 PM
$TRIB Just to add,👇restructuring nicely, cutting down costs.
0 · Reply
Think_Bigly
Think_Bigly May. 16 at 12:12 PM
$TRIB sales up 8.3% for 2024... primarily on HIV Sales into Africa. "TrinScreen HIV were US$10.0 million for the year (US$0.4 million in 2023) as we continued to see strong demand following our initial shipments in late 2023."
0 · Reply